Cisplatin and oleanolic acid Co-loaded pH-sensitive CaCO3nanoparticles for synergistic chemotherapy
Chemistry
02 engineering and technology
0210 nano-technology
3. Good health
DOI:
10.1039/d2ra00742h
Publication Date:
2022-05-16T11:28:26Z
AUTHORS (9)
ABSTRACT
Despite being one of the most potent anticancer agents, cisplatin (CDDP) clinical usage is limited owing to the acquired resistance and severe adverse effects including nephrotoxicity.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (62)
CITATIONS (31)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....